Revolution Medicines, Inc.
Ticker: 1628171
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY23 | Q2 FY23 | Q1 FY23 | Q1 FY23 | Q3 FY22 | Q3 FY22 | Q2 FY22 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 197.56+5071.7% | 3.82+0.0% | 3.82-45.5% | 7.01+0.0% | 7.01+108.6% | 3.36+0.0% | 3.36-63.2% | 9.12 |
| Total Income | 197.56+5071.7% | 3.82+0.0% | 3.82-45.5% | 7.01+0.0% | 7.01+108.6% | 3.36+0.0% | 3.36-63.2% | 9.12 |
| EXPENSES | ||||||||
| Expenditure | 570.71+406.8% | 112.62+0.0% | 112.62+37.1% | 82.17+0.0% | 82.17+2.9% | 79.89+0.0% | 79.89+12.2% | 71.21 |
| Tax | -2.35 | 0.00 | 0.00 | 0.00 | 0.00+100.0% | -0.30+0.0% | -0.30 | 0.00 |
| PROFIT | ||||||||
| PBT | -409.81-316.9% | -98.30+0.0% | -98.30-44.3% | -68.10+0.0% | -68.10+7.5% | -73.63+0.0% | -73.63-20.3% | -61.22 |
| Net Profit | -407.46-314.5% | -98.30+0.0% | -98.30-44.3% | -68.10+0.0% | -68.10+7.1% | -73.33+0.0% | -73.33-19.8% | -61.22 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -1.90-106.5% | -0.92+0.0% | -0.92-27.8% | -0.72+0.0% | -0.72+17.2% | -0.87+0.0% | -0.87-6.1% | -0.82 |
Corporate Events
Board MeetingRVMD
202618Jun
Board Meeting
Dr. Steve Kelsey's planned retirement and transition, and th…
SEC Filing ↗